Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.

Abstract

OBJECTIVE:

Elevated B-type natriuretic peptide is associated with increased morbidity and mortality in ambulatory patients with congestive heart failure or acute coronary syndromes. Its utility in predicting adverse cardiac surgical outcomes is less certain. We hypothesized that preoperative plasma B-type natriuretic peptide would independently predict in-hospital postoperative ventricular dysfunction, hospital stay, and up to 5-year mortality after primary coronary artery bypass grafting.

METHODS:

This is a prospective, longitudinal study of 1023 patients at two institutions undergoing primary coronary artery bypass grafting with cardiopulmonary bypass. Ventricular dysfunction was defined as requirement for at least two inotropes or new intra-aortic balloon pump or ventricular assist device support after coronary artery bypass grafting. Multivariable analyses assessed independent roles of preoperative B-type natriuretic peptide in predicting postoperative ventricular dysfunction, hospital stay, and 5-year all-cause mortality.

RESULTS:

Preoperative plasma B-type natriuretic peptide concentration predicted ventricular dysfunction, hospital stay, and mortality in univariate and multivariable analyses. Logistic regression demonstrated preoperative B-type natriuretic peptide to independently predict ventricular dysfunction (odds ratio 1.92, 95% confidence interval 1.12-3.29, P = .018), after adjustment for preoperative left ventricular ejection fraction, congestive heart failure severity, and other clinical predictors. Multivariable Cox proportional hazards models showed preoperative B-type natriuretic peptide to independently predict hospital stay (hazard ratio 1.42, 95% confidence interval 1.18-1.72, P = .0002) and mortality (hazard ratio 1.89, 95% confidence interval 1.08-3.33, P = .026).

CONCLUSION:

Preoperative plasma B-type natriuretic peptide independently predicted in-hospital ventricular dysfunction, hospital stay, and up to 5-year all-cause mortality after primary coronary artery bypass grafting.

• Authors: Amanda A Fox, Stanton K Shernan, Charles D Collard, Kuang-Yu Liu, Sary F Aranki, Stacia M DeSantis, Petr Jarolim, Simon C Body
• Journal: The Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 136 Issue 2 Pg. 452-61 (Aug 2008) ISSN: 1097-685X [Electronic] United States
• PMID: 18692657 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers
• Cardiotonic Agents
• Natriuretic Peptide, Brain

Topics

• Adult
• Aged
• Aged, 80 and over
• Assisted Circulation
• Biomarkers (blood)
• Cardiotonic Agents (therapeutic use)
• Coronary Artery Bypass (adverse effects, mortality)
• Female
• Humans
• Length of Stay
• Male
• Middle Aged
• Natriuretic Peptide, Brain (blood)
• Postoperative Care
• Postoperative Complications
• Survival Rate
• Ventricular Dysfunction (diagnosis, etiology)